Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator
Yae Min Park
Korean J Intern Med. 2023;38(1):7-15. Published online 2022 Nov 10 DOI: https://doi.org/10.3904/kjim.2022.144
Citations to this article as recorded by 
Echocardiographic Global Longitudinal Strain and Myocardial Fibrosis in Patients with Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy
Monika Matla-Hajzyk, Mariusz Balys, Aleksander Olejnik, Patrycja Brzoska, Maciej Haberka
Biomedicines.2026; 14(6): 1278. CrossRef
Integrative Approaches in the Management of Hypertrophic Cardiomyopathy: A Comprehensive Review of Current Therapeutic Modalities
Marco Maria Dicorato, Gaetano Citarelli, Francesco Mangini, Rossella Alemanni, Miriam Albanese, Sebastiano Cicco, Cosimo Angelo Greco, Cinzia Forleo, Paolo Basile, Maria Cristina Carella, Marco Matteo Ciccone, Andrea Igoren Guaricci, Ilaria Dentamaro
Biomedicines.2025; 13(5): 1256. CrossRef
Evaluation of sudden cardiac death in hypertrophic cardiomyopathy
Sang Gon Yoon, Geu-Ru Hong
Journal of Cardiovascular Imaging.2025;[Epub] CrossRef
Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction
Minjung Bak, Jin-Oh Choi
The Korean Journal of Internal Medicine.2023; 38(5): 595. CrossRef
Current perspectives of sudden cardiac death management in hypertrophic cardiomyopathy
Lutong Pu, Jialin Li, Weitang Qi, Jinquan Zhang, Hongyu Chen, Zihuan Tang, Yuchi Han, Jie Wang, Yucheng Chen
Heart Failure Reviews.2023; 29(2): 395. CrossRef